healthcare News

NeuroOne beats Q1 estimates, raises 2026 outlook on OneRF momentum
Healthcare
1mo ago

NeuroOne beats Q1 estimates, raises 2026 outlook on OneRF momentum

Medical device company reports stronger-than-expected earnings as trigeminal nerve ablation system gains traction

Krystal Biotech surges after beating Q4 estimates
Healthcare
1mo ago

Krystal Biotech surges after beating Q4 estimates

Gene therapy company reports 34% full-year revenue growth with strong cash position and key FDA designations

Medtronic surges on strong Q3 results as cardiovascular growth hits decade high
Healthcare
1mo ago

Medtronic surges on strong Q3 results as cardiovascular growth hits decade high

Medical device maker beats earnings estimates with 11% cardiovascular growth driven by pulsed field ablation technology

Ideaya Biosciences falls on earnings miss as investors await key March data
Healthcare
1mo ago

Ideaya Biosciences falls on earnings miss as investors await key March data

Biotech posts wider-than-expected loss but strengthens balance sheet with $1.05B cash position ahead of darovasertib trial results

Edesa Biotech narrows loss as cash reserves fuel pipeline progress
Healthcare
1mo ago

Edesa Biotech narrows loss as cash reserves fuel pipeline progress

Clinical-stage biotech advances EB06 vitiligo program and explores paridiprubart commercialization

Bio-Rad plunges 11% on earnings miss, weak 2026 outlook
Healthcare
1mo ago

Bio-Rad plunges 11% on earnings miss, weak 2026 outlook

Life science segment struggles amid constrained academic research spending, biotech funding challenges

Ultragenyx cuts 10% of staff after Phase 3 trial failures
Healthcare
1mo ago

Ultragenyx cuts 10% of staff after Phase 3 trial failures

Biotech restructuring follows failed setrusumab studies and FDA gene therapy delay, shares plunge 9.4%

Citius Pharmaceuticals reports first revenue after LYMPHIR launch
Healthcare
1mo ago

Citius Pharmaceuticals reports first revenue after LYMPHIR launch

Biotech generates $3.9 million from new cancer therapy as it works toward profitability